The rating affirmation is based on several factors, including GHS’ growing market share and solid liquidity position.
The outlook is revised to negative, reflecting continued thin operating performance through the first half of fiscal year 2016, as well as management’s expectation that performance won’t improve materially by the end of the year.
More articles on healthcare finance:
16 thoughts on personal finance: Save early and often; cut expenses; invest to your risk tolerance and more
Tenet posts $140M net loss in 2015: 6 things to know
Highmark Health to slash physician reimbursement to contain ACA losses
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
